Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
24 Cards in this Set
- Front
- Back
Dysrhythmias result from |
disorders of impulse formation, conduction of impulses or both |
|
Sinus bradycardia |
the conduction pathway is the same as in sinus rhythm, but the SA node fires at a rate of less than 60 beats/ min and is inadequate for the patient's condition, causing pt to experience symptoms |
|
Clinical associations of sinus bradycardia |
May be normal during sleep and in trained athletes -occurs in response to carotid sinus massafe, valsalva maneuver, hypothermia, increased IOP, vagal stimulation, admin of CCBs, Beta adrenergic blockers - Disease states associated w/ are hypothyroidism, increased ICP, hypoglycemia, inferior MI |
|
Sinus bradycardia ECG characteristics |
HR is less than 60 beats/min and rhythm is regular -The P wave precedes each QRS complex and has a normal shape and duration -The PR interval is normal and the QRS complex has a normal shape and duration |
|
Signs of symptomatic bradycardia include |
Clinical significance depends on how pt tolerates it -Pale, cool skin -Hypotension -weakness -Angina -dizziness / syncope -SOB, confusion, disorientation |
|
TX of sinus bradycardia |
Admin of atropine (Anticholinergic) - Pacemaker -Stop offending drugs |
|
Sinus tachycardia |
The conduction pathway is the same as normal sinus rhythm - The discharge rate from the sinus node increases because of vagal inhibition or sympathetic stimulation -The sinus rate is 101 - 200 beats/minute |
|
Clinical associations of sinus tachycardia |
Physiologic and psychologic stressors (exercise, fever, pain, hypotension, hypovolemia, anemia, hypoxia, hypoglycemia, MI, HF, hyperthyrodism. anxiety, fear -epinephrine, norepinephrine, atropine, caffeine, sudaphed, theophulline, hydralazine |
|
ECG characteristics |
HR is 101-200 beats/minute and rhythm is regular P wave normal, precedes each QRS complex and has normal shape and duration -PR interval is normal and the QRS complex has a normals shape and duration |
|
Clinical significance |
Depends on pt's tolerance to increased HR -dizziness, dyspnea, hypotension because of decreased CO -Increased myocardial oxygen consumption is associated w/ an increased HR -Angina or an increased in infraction size may accompany sinus tachy in CAD or acute MI |
|
Treatment |
underlying cause of tachycardia guides tx -treat pain -vagal maneuvers -beta adrenergic blockers can be given to reduce HR and decrease o2 consumption |
|
Atrial Fibrillation |
Stroke is the biggest risk Older and underlying heart disease are most at risk Atrial fibrillation results in a decrease in CO because ofineffective atrial contractions (loss of atrial kick) and/or a rapidventricular response. Thrombi (clots) form in the atria because of bloodstasis. An embolized clot may develop and pass to the brain, causing a stroke.Atrial fibrillation accounts for as many as 17% of all strokes. |
|
TX of A-fib |
Meds to control ventricular rate and/or convert (CBC, B-adrenergic, digoxin) Cardioversion Anticoagulation (Coumadin) Ablation |
|
Ventricular tachycardia associated w/ |
MI
CAD significant electrolyte imbalances cardiomyopathy mitral valve prolapse long QT syndrome drug toxicity central nervoussystem disorders. This dysrhythmia can be seen in patients who have no evidenceof cardiac disease. |
|
Stable v. unstable & Treatments of these |
Stable - pulse Tx: antidysrhythmics, cardioversion unstable - pulseless Tx: CPR, Rapid defibrillation |
|
Result of a sustained VT? |
Severe decrease in CO - hypotension, pulmonary edema, decreased cerebral perfusion, cardiopulmonary arrest VT is an ominous sign because of decreased CO and possible development of v-fib |
|
What do you do if the monitor shows VT? |
1) assess the patient : stable or unstable 2) call a code and start CPR |
|
Ventricular fibrillation associate w/ |
MI, ischemia, disease states, procedures |
|
Pt is likely to be |
unresponsive, pulseless, apneic |
|
Treatment: |
CPR and ACLS -defibrillation -Drug therapy (epic, vasopressin) untreated = death |
|
Monitor shows V-fib: |
1) assess 2) start CPR and call a code |
|
Atrial flutter caused by: |
Diseases: CAD, HTN, mitral valve disorders, PE, chronic lung disease, cor pulmonale, cardiomyopathy, hyperthyrodism, Drugs: digoxin, quinidine, epinephrine Stroke risk because of the risk of thrombus formation in the atria from the stasisof blood. Warfarin (Coumadin) is given to prevent stroke in patients who haveatrial flutter. |
|
Treatment: |
Meds Cardioversion Ablation •Slow ventricularresponse with calcium channel blockers and β-adrenergic blockers. •Convert withantidysrhythmics - ibutilide [Corvert])•Maintain sinusrhythm (e.g., amiodarone, flecainide [Tambocor], dronedarone [Multaq]).•Cardioversion inan emergency (i.e., the patient is hemodynamically unstable) and electively. •Ablation -treatment of choice for atrial flutter. Tissue is ablated(or destroyed), the dysrhythmia is ended, and normal sinus rhythm is restored. |
|
Pacemakers indications |
Permanent pacemakers are used for chronic heart problems inwhich heart beats too slowly to adequately support perfusion (i.e., AV heartblocks, sick sinus syndrome, atrial fibrillation with slow ventricularresponse, severe heart failure, cardiomyopathy, bundle branch block). |